Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.43B |
| 2 |
Qualcomm
QCOM
|
+$478M |
| 3 |
Oracle
ORCL
|
+$385M |
| 4 |
CELG
Celgene Corp
CELG
|
+$343M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.12B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$781M |
| 3 |
Energy Transfer Partners
ET
|
+$384M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.83% |
| 2 | Financials | 5.79% |
| 3 | Healthcare | 5.06% |
| 4 | Consumer Discretionary | 4.03% |
| 5 | Industrials | 3.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Ingredion
INGR
$6.58B
| $4.55M | ﹤0.01% |
55,199
+28,844
| +109% | +$2.48M |
|
2027
Madrigal Pharmaceuticals
MDGL
$11.8B
| $4.55M | ﹤0.01% |
43,365
+42,341
| +4,135% | +$4.54M |
|
2028
CALL
General Mills
GIS
$19.7B
| $4.53M | ﹤0.01% |
86,300
-61,600
| -42% | -$3.18M |
|
2029
NIO
NIO
$11.9B
| $4.53M | ﹤0.01% |
1,776,700
+679,982
| +62% | +$2.73M |
|
|
UNIT
2030
Uniti Group
UNIT
$2.32B
| $4.53M | ﹤0.01% |
476,828
+286,768
| +151% | +$3.13M |
|
|
DGBP
2031
DELISTED
Exchange-Traded Notes linked to the VelocityShares Daily 4X Long USD vs. GBP Index due December 6, 2
DGBP
| $4.53M | ﹤0.01% |
148,500
-2,000
| -1% | -$57.9K |
|
2032
PUT
Illinois Tool Works
ITW
$84.5B
| $4.51M | ﹤0.01% |
29,900
+5,600
| +23% | +$845K |
|
|
CIR
2033
DELISTED
CIRCOR International, Inc
CIR
| $4.5M | ﹤0.01% |
97,906
+71,378
| +269% | +$2.76M |
|
2034
CALL
Howmet Aerospace
HWM
$112B
| $4.49M | ﹤0.01% |
226,766
+10,041
| +5% | +$169K |
|
2035
PUT
Northern Oil and Gas
NOG
$2.35B
| $4.47M | ﹤0.01% |
231,520
+1,480
| +0.6% | +$34.2K |
|
2036
First Trust Health Care AlphaDEX Fund
FXH
$1.08B
| $4.46M | ﹤0.01% |
57,652
-2,355
| -4% | -$175K |
|
2037
CALL
M&T Bank
MTB
$36.2B
| $4.46M | ﹤0.01% |
26,200
+7,900
| +43% | +$1.31M |
|
2038
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
| $4.45M | ﹤0.01% |
23,883
+228
| +1% | +$41.5K |
|
2039
Viking Therapeutics
VKTX
$4B
| $4.44M | ﹤0.01% |
534,904
+478,867
| +855% | +$4.09M |
|
2040
Vodafone
VOD
$37.4B
| $4.44M | ﹤0.01% |
271,638
-465,333
| -63% | -$8M |
|
2041
CALL
Martin Marietta Materials
MLM
$33B
| $4.42M | ﹤0.01% |
19,200
-86,200
| -82% | -$18.7M |
|
2042
Jefferies Financial Group
JEF
$13.1B
| $4.42M | ﹤0.01% |
256,469
+101,337
| +65% | +$1.74M |
|
2043
PUT
Ciena
CIEN
$58.4B
| $4.41M | ﹤0.01% |
107,300
+29,500
| +38% | +$1.14M |
|
2044
PUT
AstraZeneca
AZN
$250B
| $4.41M | ﹤0.01% |
53,400
+1,600
| +3% | +$125K |
|
2045
PUT
Dillards
DDS
$9.56B
| $4.41M | ﹤0.01% |
70,800
+14,500
| +26% | +$932K |
|
2046
Bio-Rad Laboratories Class A
BIO
$9.42B
| $4.4M | ﹤0.01% |
14,078
-368
| -3% | -$110K |
|
2047
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
| $4.4M | ﹤0.01% |
59,168
-1,828
| -3% | -$136K |
|
2048
Encore Capital Group
ECPG
$2.13B
| $4.4M | ﹤0.01% |
129,808
+60,310
| +87% | +$1.96M |
|
2049
CALL
Agnico Eagle Mines
AEM
$90.5B
| $4.38M | ﹤0.01% |
85,300
-25,600
| -23% | -$1.12M |
|
2050
CALL
Campbell Soup
CPB
$6.87B
| $4.38M | ﹤0.01% |
109,300
-160,000
| -59% | -$6.28M |
|
Similar funds
Citigroup's Q2 2019 Portfolio in Review
As of Q2 2019, Citigroup held 8,008 positions worth $124B, up 19% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup deployed $16.7B of net new capital in Q2 2019, opening 295 new positions and adding to 4,221 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.12B trimmed.
- Citigroup's largest Q2 2019 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
- Citigroup added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $2.43B increase.
- Citigroup's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.12B.
- Citigroup fully exited Integrated Device Technology I in Q2 2019, selling an estimated $126M.
- Citigroup's ten largest holdings make up 21% of its $124B portfolio in Q2 2019.
- Citigroup opened 295 new positions and closed 217 in Q2 2019.
- Citigroup's portfolio value rose 19% quarter-over-quarter to $124B.
Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.